Evidence map›Paper›PMID 42213198›Full record

ArticleJournal of computer-aided molecular design2026

Target-aware molecule SMILES generation using a large language model with retrieval-augmented generation, multi-turn memory, and a predictive model.

Piotr Karabowicz, Radosław Charkiewicz, Alicja Charkiewicz, Jacek Nikliński

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Piotr KarabowiczDepartment of Clinical Molecular Biology, Medical University of Bialystok, 15-269, Bialystok, Poland. piotr.karabowicz@umb.edu.pl.ORCID 0000-0002-8072-2104
Radosław CharkiewiczDepartment of Clinical Molecular Biology, Medical University of Bialystok, 15-269, Bialystok, Poland.
Alicja CharkiewiczDepartment of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089, Bialystok, Poland.
Jacek NiklińskiDepartment of Clinical Molecular Biology, Medical University of Bialystok, 15-269, Bialystok, Poland.

Funding

Uniwersytet Medyczny w Bialymstoku B.SUB.26.512
6 · The paper itself

Abstract

Given the vastness of chemical space and the cost and time requirements of high-throughput screening, resource-efficient computational strategies are needed to prioritize candidate drug molecules. Here, we evaluated whether an open-weight large language model (LLM) augmented with retrieval-augmented generation (RAG), multi-turn memory, and a pretrained drug-target interaction predictor can generate target-aware molecules without task-specific retraining. Protein-ligand-pKi examples retrieved from BindingDB, Davis, and KIBA were used as contextual guidance, while DeepPurpose provided the optimization signal during iterative SMILES refinement. Our approach produced a statistically significant increase in predicted pKi across successive multi-turn memory iterations, indicating that retrieval- and memory-guided refinement may improve target-conditioned molecular generation. The proposed framework also showed favorable molecular generation characteristics, with novelty reaching 100%, diversity up to 0.882, and uniqueness up to 1.0, suggesting that retrieval did not reduce the process to simple reproduction of known ligands but instead supported exploration of new regions of chemical space. In addition, the approach yielded supportive docking results consistent with the generation of chemically relevant candidate ligands. However, the increase in predicted affinity was accompanied by trade-offs in molecular quality, including reduced validity and drug-likeness in later iterations. Taken together, these findings suggest that this framework provides a flexible and comparatively resource-efficient strategy for target-aware de novo molecular design, while further multi-objective optimization and independent validation remain necessary.

Indexed as

Drug DiscoveryProteinsSmall Molecule LibrariesDrug DesignHumansLarge Language ModelsLigandsLigandsProteinsSmall Molecule LibrariesDrug discoveryLarge language modelsMulti-turn memoryRetrieval-augmented generationSMILES generation

Identifiers

PMID42213198
PMCPMC13221405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.